Variational Ai

Variational Ai company information, Employees & Contact Information

Updated May 2026

Quick answer

Variational Ai is a Biotechnology Research company and founded in 2019. It has approximately 22 employees on record. Contact data was last refreshed in May 2026. Find Variational Ai's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Variational AI has developed Enki, the biopharma industry's first commercially-available foundation model for small molecules. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.

Company Details

Employees
22
Founded
-
Address
Vancouver, Bc V5t 1e1, Ca
Email
in****@****onal.ai
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Vancouver, BC
Looking for a particular Variational Ai employee's phone or email?

Variational Ai Questions

News

Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery - Business Wire

Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery Business Wire

Merck inks $349M biobucks deal to apply AI to challenging targets - Fierce Biotech

Merck inks $349M biobucks deal to apply AI to challenging targets Fierce Biotech

Merck & Co. taps Variational AI's generative platform for $349M drug design deal - FirstWord Pharma

Merck & Co. taps Variational AI's generative platform for $349M drug design deal FirstWord Pharma

Variational AI, Merck Partner in $349M AI Drug Discovery Deal - WebProNews

Variational AI, Merck Partner in $349M AI Drug Discovery Deal WebProNews

Variational AI lands “up to” $349 million USD to discover drugs with Merck - BetaKit

Variational AI lands “up to” $349 million USD to discover drugs with Merck BetaKit

MSD's $345m alliance with Variational, and other AI news - pharmaphorum

MSD's $345m alliance with Variational, and other AI news pharmaphorum

Variational AI inks drug discovery deal with Merck worth up to $349-million - The Globe and Mail

Variational AI inks drug discovery deal with Merck worth up to $349-million The Globe and Mail

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery - Yahoo Finance

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery Yahoo Finance

Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award - GlobeNewswire

Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award GlobeNewswire

Merck enters $349M deal with Variational AI for drug discovery collaboration - StreetInsider

Merck enters $349M deal with Variational AI for drug discovery collaboration StreetInsider

Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development - Insider Monkey

Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development Insider Monkey

Biotech Startup Attracts US$350M Deal to Accelerate Drug Discovery with AI - techcouver.com

Biotech Startup Attracts US$350M Deal to Accelerate Drug Discovery with AI techcouver.com

Variational AI: $5.5 Million Raised For Small Molecule Drug Discovery - Pulse 2.0

Variational AI: $5.5 Million Raised For Small Molecule Drug Discovery Pulse 2.0

Fast-growing Variational AI raises US$5.5M to bring technology to market - Business in Vancouver

Fast-growing Variational AI raises US$5.5M to bring technology to market Business in Vancouver

Merck (MRK) Stock Rises on AI Drug Discovery Agreement - GuruFocus

Merck (MRK) Stock Rises on AI Drug Discovery Agreement GuruFocus

Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI - GlobeNewswire

Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI GlobeNewswire

Merck partners with Variational AI for drug discovery - Chemical & Engineering News

Merck partners with Variational AI for drug discovery Chemical & Engineering News

Merck finds drug discovery DALL-E, becoming early user of small molecule generative AI tool - Fierce Biotech

Merck finds drug discovery DALL-E, becoming early user of small molecule generative AI tool Fierce Biotech

Variational AI Announces Generative AI Project With Merck - Business Wire

Variational AI Announces Generative AI Project With Merck Business Wire

B.C.’s AI investment climate remains strong as sector develops - Business in Vancouver

B.C.’s AI investment climate remains strong as sector develops Business in Vancouver

B.C. AI venture Variational AI partners with Merck - Business in Vancouver

B.C. AI venture Variational AI partners with Merck Business in Vancouver

Takeda expands de novo protein research by signing second deal with AI specialist Nabla Bio - Endpoints News

Takeda expands de novo protein research by signing second deal with AI specialist Nabla Bio Endpoints News

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference - Investing News Network

Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference Investing News Network

Cutting through the noise of machine learning for drug discovery - drugdiscoverytrends.com

Cutting through the noise of machine learning for drug discovery drugdiscoverytrends.com

Merck Partners with Variational AI to Accelerate Drug Discovery Using Enki™ Generative Platform - Quantum Zeitgeist

Merck Partners with Variational AI to Accelerate Drug Discovery Using Enki™ Generative Platform Quantum Zeitgeist

Invivo aims to raise €100M for fourth fund; SEED Therapeutics gets $30M - Endpoints News

Invivo aims to raise €100M for fourth fund; SEED Therapeutics gets $30M Endpoints News

Revolution, interrupted: Why AI has failed to live up to the hype in drug development - The Globe and Mail

Revolution, interrupted: Why AI has failed to live up to the hype in drug development The Globe and Mail

What Is VAE in Stable Diffusion? - Built In

What Is VAE in Stable Diffusion? Built In

Rakovina Therapeutics to Present New Data Highlighting - GlobeNewswire

Rakovina Therapeutics to Present New Data Highlighting GlobeNewswire

What is a variational autoencoder (VAE)? - TechTarget

What is a variational autoencoder (VAE)? TechTarget

Radical Ventures closes $650-million early-stage AI fund - The Globe and Mail

Radical Ventures closes $650-million early-stage AI fund The Globe and Mail

Meta’s super PAC, Trump’s talent tariff, MDA Space goes rinkside - BetaKit

Meta’s super PAC, Trump’s talent tariff, MDA Space goes rinkside BetaKit

Generative AI already powering dozens of B.C.-based companies - Business in Vancouver

Generative AI already powering dozens of B.C.-based companies Business in Vancouver

Team BC Showcases AI Leadership at Canada’s Largest AI Conference - techcouver.com

Team BC Showcases AI Leadership at Canada’s Largest AI Conference techcouver.com

Google releases free version of AI platform that speeds coding - Business in Vancouver

Google releases free version of AI platform that speeds coding Business in Vancouver

Canadian healthcare ventures nab $26M for AI innovations - Business in Vancouver

Canadian healthcare ventures nab $26M for AI innovations Business in Vancouver

Canada is behind in 'sovereign AI compute' but two B.C.-focused projects aim to change that - Vancouver Sun

Canada is behind in 'sovereign AI compute' but two B.C.-focused projects aim to change that Vancouver Sun

B.C. AI CEOs excited Canada has first dedicated minister of AI - Business in Vancouver

B.C. AI CEOs excited Canada has first dedicated minister of AI Business in Vancouver

Pros and cons of A.I. capture attention of B.C. businesses - Vancouver Sun

Pros and cons of A.I. capture attention of B.C. businesses Vancouver Sun

France’s Mistral AI plans expansion into Canada - The Globe and Mail

France’s Mistral AI plans expansion into Canada The Globe and Mail

KPMG teams with Microsoft to teach free AI, cybersecurity skills - Business in Vancouver

KPMG teams with Microsoft to teach free AI, cybersecurity skills Business in Vancouver

AI will be ‘transformative’ for B.C.'s engineering industry - Business in Vancouver

AI will be ‘transformative’ for B.C.'s engineering industry Business in Vancouver

Drug research turns to artificial intelligence in COVID-19 fight - Business in Vancouver

Drug research turns to artificial intelligence in COVID-19 fight Business in Vancouver

How artificial intelligence is already powering work in B.C. - Business in Vancouver

How artificial intelligence is already powering work in B.C. Business in Vancouver

Miningcoop Launches Free AI-Powered Cloud Mining Platform for Bitcoin in 2025, Empowering Global Crypto Investors Amid Bull Market Surge - The Manila Times

Miningcoop Launches Free AI-Powered Cloud Mining Platform for Bitcoin in 2025, Empowering Global Crypto Investors Amid Bull Market Surge The Manila Times

Variational Autoencoders Simply Explained - Becoming Human: Artificial Intelligence Magazine

Variational Autoencoders Simply Explained Becoming Human: Artificial Intelligence Magazine

B.C. lawyer alleged to have used AI program for case law - Vancouver Is Awesome

B.C. lawyer alleged to have used AI program for case law Vancouver Is Awesome

Top Variational Ai Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant